High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer

BJU International

Volumn 111, Issue 5, 2013, Pages 836-842

  Smit, Frank P ^d   Salagierski, MacIej ^a,b   Jannink, Sander ^d   Schalken, Jack A ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NovioGendix   (Netherlands)

Author keywords

diagnosis; ERG; prostate cancer; TMPRSS2 ERG fusions

Indexed keywords

MEMBRANE PROTEIN; TRANSCRIPTION FACTOR ER81; TRANSMEMBRANE PROTEIN SERINE 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CASTRATION RESISTANT PROSTATE CANCER; CONTROLLED STUDY; DNA SEQUENCE; ESTROGEN REGULATED GENE; EXON; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUSION; GENE REARRANGEMENT; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GENE;

ADULT; AGED; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; ORCHIECTOMY; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANS-ACTIVATORS;

EID: 84876234101     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12119     Document Type: Article

References (18)

1. Boyle P, Ferlay J,. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.
2. Roobol MJ, Zappa M, Maattanen L, Ciatto S,. The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC). Prostate 2007; 67: 439-446.
3. Mitelman F, Johansson B, Mertens F,. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007; 7: 233-245
4. Haffner MC, Aryee MJ, Toubaji A, et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 2010; 42: 668-675
5. Demichelis F, Fall K, Perner S, et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 2007; 26: 4596-4599
6. Yoshimoto M, Joshua AM, Cunha IW, et al. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol 2008; 21: 1451-1460
7. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007; 31: 882-888
8. Perner S, Demichelis F, Beroukhim R, et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res, 2006; 66: 8337-8341
9. Hessels D, Smit FP, Verhaegh GW, Witjes JA, Cornel EB, Schalken JA,. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 2007; 13: 5103-5108
10. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310: 644-648
11. Jhavar S, Reid A, Clark J, et al. Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. J Mol Diagn 2008; 10: 50-57
12. Duan S, Zhang W, Bleibel WK, Cox NJ, Dolan ME. SNPinProbe-1,. 0: A database for filtering out probes in the Affymetrix GeneChip(R) Human Exon 1.0 ST array potentially affected by SNPs. Bioinformation 2008; 2: 469-470
13. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries, of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31: e15
14. Hessels D, Smit FP, Verhaegh GW, Witjes JA, Cornel EB, Schalken JA,. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 2007; 13: 5103-5108
15. Mehra R, Tomlins SA, Shen R, et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol 2007; 20: 538-544
16. Attard G, Clark J, Ambroisine L, et al. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br J Cancer 2008; 99: 314-320
17. Rowley JD., Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 2001; 1: 245-250
18. Tomlins SA, Bjartell A, Chinnaiyan AM, et al. ETS gene fusions in prostate cancer: from discovery to daily clinical practice. Eur Urol 2009; 56: 275-286